$CRMT

AMERICAS CARMART INC (CRMT): Results of Operations and Financial Condition

AMERICAS CARMART INC (CRMT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exh_991.htm PRESS RELEASE EdgarFiling EXHIBIT 99.1 America’s Car-Mart Reports Fourth Quarter and Fiscal Year 2026 Results ROGERS, Ark., July 14, 2026 (GLOBE NEWSWIRE) -- America’s Car-Mart, Inc. (NASDAQ: CRMT) (“we,” “Car-Mart” or the “Company”), today reported financia

Original reporting
Published Jul 14, 2026, 1:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 14, 2026, 1:16 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$CRMT
Bearish
high confidence
Mentioned
$CRMT
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CRMTBearishMed
01

Why it matters

Traders should focus on (1) the direction of credit metrics (net charge-offs ratio), (2) margin compression from volume mix and fixed cost leverage, and (3) the refinancing/strategic alternatives timeline implied by covenant relief and going-concern disclosure.

02

Market read

A primary earnings and liquidity update for CRMT with explicit covenant relief, going-concern context, and worsening operating and credit ratios.

03

What to watch

The going-concern and covenant relief could also reduce immediate default probability if milestones are met, making the refinancing timeline a key swing factor beyond the headline earnings declines.

Relevance 7/10Novelty 8/10Timing: after-hours/filing today with FY26 and Q4 results plus June 19 credit agreement amendment details

Background

The 8-K includes a press release for Q4 and FY ended April 30, 2026, and references a June 19, 2026 amendment to the company’s senior secured term loan credit agreement.

Company-level read

Ticker impact

$CRMTBearishHigh confidence
Context

America’s Car-Mart reports FY26 and Q4 results plus a June 19, 2026 credit agreement amendment tied to liquidity and strategic alternatives review.

Expected impact

Higher volatility and downside bias until the strategic alternatives review and additional financing path becomes clearer.

Evidence & confidence

This is a primary 8-K earnings release with concrete datapoints (revenue down 7.9%, sales volumes down 14.3%, net charge-offs ratio up) and a specific covenant/financing amendment plus going-concern disclosure reference.

Market effects

Read-across risk for used-car finance and dealership-lender models where liquidity constraints can force inventory and origination pullbacks.

Limited direct regional spillover; impacts are primarily company-specific credit and refinancing dynamics.

Low global relevance; US-focused credit and dealership operations.

Counterpoint

Management frames the story as liquidity and capital-structure rather than credit-quality deterioration, citing relatively stable underlying credit behavior.

Key entities

  • America’s Car-Mart, Inc.

    Reports Q4 and FY26 financial results and discloses covenant relief and a liquidity-constrained strategic alternatives review.

  • Senior secured term loan lenders

    Parties to the June 19, 2026 credit agreement amendment providing covenant relief and milestones.

Related articles

$CRMTMed

Mart (CRMT) Stock Is Up Today

America’s Car-Mart (CRMT) shares rose 4.7% after the company reported Q1 adjusted earnings of $0.48 per share, above expectations, despite revenue falling 18% to $302.8 million and same-store sales down 6.1%. Stock later traded around $3.07, up 1.7% from the prior close.

$CRMTMedAI 8/10

America’s Car-Mart Reports Fourth Quarter and Fiscal Year 2026 Results

America’s Car-Mart (NASDAQ: CRMT) reported FY2026 revenue of $1.2815B, down 7.9%, with interest income up 3.7% to $253.7M. Sales volume fell 14.3% to 48,891 units and gross margin was 35.4% (vs 36.7%). It posted a FY2026 loss per share of $16.79 and adjusted loss per share of $3.71, with net charge-offs at 27.6%. The company amended its credit agreement June 19, 2026.

$LLYMedAI 8/10

Eli Lilly and Company Q2 Earnings Call Highlights

Eli Lilly (LLY) reported Q2 U.S. revenue up 33% led by ZEPBOUND and MOUNJARO volume, while U.S. price fell 3% (9% excluding rebate and discount estimate changes). International revenue rose in constant currency, with MOUNJARO a key driver. Lilly raised its 2026 revenue outlook to $85B-$87B and guided non-GAAP EPS $35.50-$36.50. It also discussed Medicare GLP-1 coverage expansion and retatrutide Phase III results.

$BRK-BMed

Berkshire Hathaway Just Did Something It Hasn’t Done in More Than 3 Years

Berkshire Hathaway reported Q2 2026 cash and Treasury bills of $365.5 billion, down from $397.4 billion in Q1, ending a 14-quarter streak as a net seller. According to Berkshire, CEO Greg Abel became a net buyer of equities, adding about $20 billion net, and increased buybacks to $4.5 billion. Apple fell to 20% of the portfolio; Alphabet rose after a $10 billion investment.

$LIONMed

Lionsgate Studios Q1 Earnings Call Highlights

Lionsgate (NYSE:LION) Q1 earnings call said it expects downstream revenue from films through fiscal 2027 and that The Hunger Games: Sunrise on the Reaping could support later-year results. Television revenue was $189 million, segment profit $10 million. Trailing 12-month library revenue was $987 million, backlog $1.5 billion. Net debt fell $121 million to about $1.5 billion; leverage improved to 4.3x.